Prevalence and Clinical Outcomes of Human Epidermal Growth Factor Receptor 2 Expression in Patients With Advanced Urothelial Carcinoma.

World J Oncol · 2025 · PMC11750760 · PMID 39850531

Europe PMC DOI

hedged sentence

0.1330

closest p · 2.7× alpha

0.1330

boldest claim

The sentences

did not reach statistical significanceP = 0.133not close (p > 0.1)

HER2-positive (score 3+) patients had a median overall survival of 9 months compared to 31 months for the HER2-negative, low and equivocal group (scores 0, 1+, 2+), though this difference did not reach statistical significance (P = 0.133).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.